
Linaglip 5mg Tablet
Marketer
Aristo Pharmaceuticals Pvt Ltd
Salt Composition
Linagliptin (5mg)
Overview Linaglip 5mg Tablet
Glycip 5mg tablets manage type 2 diabetes, complementing a balanced diet and regular physical activity to regulate blood glucose. This helps prevent severe diabetic complications, including vision loss and kidney impairment. Glycip 5mg is typically prescribed when diet, exercise, or other medications prove inadequate. Your physician may prescribe it alone or with other antidiabetic agents, with or without food. Dosage depends on your health status and glucose levels; adhere strictly to your doctor's instructions. Discontinue only under medical supervision. Maintaining your prescribed diet and exercise regimen is crucial. Lifestyle significantly impacts diabetes management. Hypoglycemia is a common side effect; learn to recognize symptoms like faintness, sweating, dizziness, and loss of consciousness, and keep readily available glucose sources. Nasopharyngitis may also occur. Report persistent or concerning side effects. Inform your doctor of any history of kidney, heart, or pancreatic issues before commencing treatment. Interactions with other medications are possible; disclose all current medications. Pregnant or lactating individuals should seek medical advice before use. Moderate alcohol consumption is recommended due to an increased hypoglycemia risk. Regular blood glucose and kidney function monitoring may be required to assess treatment effectiveness.
Uses of Linaglip 5mg Tablet
Managing type 2 diabetes
Major Benefits of Linaglip 5mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or breaking it. Linaglip 5mg Tablets can be consumed with or without food, although consistent timing is recommended.
Common Side effects of Linaglip 5mg Tablet:
- Hypoglycemia (low blood glucose level)
- Nasopharyngitis (inflammation of the throat and nasal passages)
- Cough
- Vomiting
- Diarrhea
- Constipation
How to use Linaglip 5mg Tablet:
Administer this medication precisely as directed by your physician, adhering to both the prescribed dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. The 5mg Linaglip tablet can be consumed with or without food, although consistent daily timing is recommended.
How Linaglip 5mg Tablet works:
Linaglip 5mg tablets manage type 2 diabetes by stimulating pancreatic insulin secretion and suppressing hyperglycemic hormones, thereby lowering both fasting and postprandial glucose concentrations.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Linaglip 5mg Tablet is inadvisable.
PregnancyCONSULT YOUR DOCTOR
Data on the use of Linaglip 5mg tablets in pregnancy is lacking. Seek medical advice from your physician.
Breast feedingCONSULT YOUR DOCTOR
Data on the safety of Linaglip 5mg Tablet while breastfeeding is absent. Seek medical advice from your physician.
DrivingSAFE
Driving ability is typically unaffected by Linaglip 5mg Tablets.
KidneySAFE IF PRESCRIBED
Linaglip 5mg tablets can be administered to patients with kidney disease without altering the dosage. Nevertheless, caution is advised when prescribing Linaglip 5mg tablets to individuals experiencing end-stage renal disease (ESRD) or undergoing dialysis.
LiverSAFE IF PRESCRIBED
Linaglip 5mg tablets are considered safe for individuals with liver impairment; no dosage modification is advised. Nevertheless, administration of Linaglip 5mg tablets is not recommended for those experiencing severe hepatic dysfunction.
What if you forget to take Linaglip 5mg Tablet :
Should you forget a Linaglip 5mg Tablet dose, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Linaglip 5mg Tablet
| Label | Value |
|---|---|
| Chemical Classification | Purine-quinazoline hybrid |
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
| Actions | Dipeptidyl peptidase-4 inhibitors |
